PROTOCOL NRG-BN001 – Closure notice for advanced imaging sites enrolling to Group I: Photon Cohort

 

Accrual for advanced imaging sites enrolling to the Photon Cohort (Group I) of NRG-BN001, “Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma,” will close at 5 PM ET Friday, July 20, 2018, because it has reached its accrual target.

Eligible patients registered to Group I, Step I registration by 5 PM ET Friday, may proceed to Group I, Step II randomization per Group I protocol timelines.

The Proton Cohort (Group II) will remain open to patient accrual for all sites, including advanced imaging sites.

Reminder: Data collection and site IRB renewal for closed studies must continue until the study is terminated.

Please distribute this information to the appropriate personnel at participating affiliate/NCORP component institutions.

 

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse